Envision Healthcare was Downgraded to a Hold Rating at Raymond James


Raymond James analyst John Ransom downgraded Envision Healthcare (NYSE: EVHC) to Hold on June 12. The company’s shares closed yesterday at $44.78.

According to TipRanks.com, Ransom is a 4-star analyst with an average return of 11.4% and a 62.1% success rate. Ransom covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Surgery Partners Inc, and Syneos Health Inc.

Currently, the analyst consensus on Envision Healthcare is Hold and the average price target is $44, representing a -1.7% downside.

In a report issued on June 11, William Blair also downgraded the stock to Hold.

See today’s analyst top recommended stocks >>

Based on Envision Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.08 billion and GAAP net loss of $101 million. In comparison, last year the company had a GAAP net loss of $445 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Envision Healthcare Corp. engages in the provision of healthcare services. It operates through the Physician Services and Ambulatory Services segments. The Physician Services segment provides hospital-based and non-hospital-based physician services business.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts